Inhibikase Therapeutics (IKT)
Develops IKT-001 as a clinical-stage therapy for pulmonary arterial hypertension.
$2.31
After hours−0.01 (−0.43%)
At close$2.32(+5.45%)
Something off on this page? Send us feedback.
Next report
Nov 13, 26
in 52 days
EPS estimate
−$0.11
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.88−$0.15−$0.11−$0.13−$0.09−$0.10−$0.11Pending
Estimate−$0.10−$0.11−$0.09−$0.13−$0.12−$0.10−$0.11−$0.11
Surprise+980.0%−36.4%−22.2%0.0%+25.0%0.0%−2.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.13 | — | — |
| Sep 2027 | −$0.12 | — | — |
| Jun 2027 | −$0.13 | — | — |
| Mar 2027 | −$0.13 | — | — |
| Dec 2026 | −$0.12 | — | — |
| Nov 2026 | −$0.11 | — | — |
| Aug 2026 | −$0.11 | −$0.11 | −2.3% |
| May 2026 | −$0.10 | −$0.10 | 0.0% |
| Mar 2026 | −$0.12 | −$0.09 | +25.0% |
| Nov 2025 | −$0.13 | −$0.13 | 0.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Mar 2017 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.13 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.12 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.13 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.13 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.12 | — | — | $500.0K | — | — | — |
| Nov 13, 2026 | −$0.11 | — | — | $0 | — | — | — |
| Aug 11, 2026 | −$0.11 | −$0.11 | −2.3% | — | — | — | −2.0% |
| May 12, 2026 | −$0.10 | −$0.10 | 0.0% | — | — | — | −5.4% |
| Mar 26, 2026 | −$0.12 | −$0.09 | +25.0% | — | — | — | 0.0% |
| Nov 14, 2025 | −$0.13 | −$0.13 | 0.0% | — | — | — | −4.4% |
| Aug 14, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 15, 2024 | |||||||
| Mar 27, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 16, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 12, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Mar 31, 2017 |